Hopfner Robert Lorne (CIK 1551966) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-12-22). Recent activity: Buy EVMN (1,000 shares), Buy EVMN (3,026 shares), Buy EVMN (1.4M shares), Buy EVMN (1.6M shares), Buy EVMN (294,502 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-22 | Evommune, Inc. (EVMN) | Director | Buy | 1,000 | $17,350 |
| 2025-11-12 | Evommune, Inc. (EVMN) | Director | Buy | 3,026 | $0 |
| 2025-11-12 | Evommune, Inc. (EVMN) | Director | Buy | 1.4M | $0 |
| 2025-11-12 | Evommune, Inc. (EVMN) | Director | Buy | 1.6M | $0 |
| 2025-11-12 | Evommune, Inc. (EVMN) | Director | Buy | 294,502 | $0 |
| 2025-07-03 | Inozyme Pharma, Inc. (INZY) | Director | Sell | 2.9M | $11.7M |
| 2025-07-03 | Inozyme Pharma, Inc. (INZY) | Director | Sell | 1.6M | $6.3M |
Source: SEC Form 4 filings · as of 2025-12-22